AsymBio

AsymBio is a technology-driven global CDMO specializing in biologics, bioconjugates (ADCs, AOCs, PDCs, RDCs), antibodies and recombinant proteins. We deliver comprehensive end-to-end CDMO services from early-stage R&D to commercial-scale manufacturing, backed by GMP-compliant facilities meeting US, EU and China standards.
​
Purchase on Scientist.com
​

Subscribe to our newsletter

Subscribe to receive the latest news and innovations straight to your inbox.

The Latest Insights & Innovations from

AsymBio

Webinars
Blogs
Podcasts
​
ON DEMAND
​
Webinar

Accelerating Conjugation Process Development for Next-Generation ADCs: Key Considerations and Platform Strategies

March 26, 2026
Learn more
​
ON DEMAND
​
Webinar

ADC Payload-Linker CMC Process Development Strategy

February 26, 2026
Learn more
​
ON DEMAND
​
Webinar

ADCs on The Horizon: The Performance and Prospect of Cell Line Development Platform AmigoCHO

February 5, 2026
Learn more
No items found.
No items found.
​
See it in Action

The Digital Backbone for Modern Life Sciences

Discover how one intelligent platform helps teams connect providers, workflows, approvals, compliance, data, and spend—so complex projects move faster with greater visibility and control.

​
Request a Personalized Demo